FDG-PET hypermetabolism can be observed in mild cognitive impairment (MCI), but the link to primary pathologies of Alzheimer’s diseases (AD) including amyloid and tau is unclear. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.